Phase 3 Vasculitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 50 years of age or older
- You have been diagnosed with giant cell arteritis (a condition affecting certain arteries) and meet at least 2 out of 4 specific criteria set by the American College of Rheumatology
- Your diagnosis was confirmed by at least one of the following: a biopsy of the temporal artery (a small artery near the temple), a scan showing inflammation of the large artery in the chest or abdomen, or an ultrasound scan compatible with this diagnosis
- You have been taking steroid tablets (such as prednisolone) for no more than 14 days, at a starting dose of 1 mg per kilogram of body weight or less
- You have given written consent to take part in the trial
- You are covered by social security (confirm with trial site, as this may relate to the French healthcare system)
Who may not be able to join:
- You were treated for this condition with a steroid dose higher than 1 mg per kilogram of body weight
- You have already been taking steroid tablets for more than 14 days
- Your giant cell arteritis has come back after a previous episode (a relapse)
- You have been diagnosed with dementia
- You are unlikely to follow the trial's requirements as assessed by the medical team
- You live more than 150 km (about 93 miles) away from the trial centre
- You are under legal protection or guardianship
- You have a known allergy or sensitivity to prednisone (a type of steroid) or any of its ingredients
- You currently have an infection that requires treatment taken by mouth or injection
- You have an active viral infection such as hepatitis, herpes, or chickenpox
- You have received a live or weakened live vaccine within the 8 weeks before joining the trial
- You are pregnant, breastfeeding, or are a woman who could become pregnant and are not using contraception
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hubert De BOYSSON, MD, University Hospital, Caen
Phone: 02 31 06 57 32
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient in complete remission over a follow up of 52 weeks, without relapse
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.